Source: Health Canada shortage reports · Updated Aug 6, 2026
A shortage of Apixaban is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
A blood thinner used to prevent and treat blood clots.
Products affected
0 / 11
Reports on file
32
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Anticipated
APIXABAN
2.5MG · TABLET · SANIS HEALTH INC
DIN 02548879 · Disruption of the manufacture of the drug.
Resolved
SANDOZ APIXABAN SDZ
5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489236 · ended Aug 3, 2026 · Delay in shipping of the drug.
Resolved
SANDOZ APIXABAN SDZ
5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489236 · ended Aug 3, 2026 · Delay in shipping of the drug.
Resolved
SANDOZ APIXABAN SDZ
5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489236 · ended Mar 23, 2026 · Delay in shipping of the drug.
Resolved
SANDOZ APIXABAN SDZ
5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489236 · ended Mar 20, 2026 · Delay in shipping of the drug.
Resolved
SANDOZ APIXABAN SDZ
2.5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489228 · ended Feb 2, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
TARO-APIXABAN
5MG · TABLET · SUN PHARMA CANADA INC
DIN 02510472 · ended Jan 21, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ APIXABAN SDZ
2.5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489228 · ended Jan 8, 2026 · Delay in shipping of the drug.
Resolved
SANDOZ APIXABAN SDZ
5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489236 · ended Dec 12, 2025 · Disruption of the manufacture of the drug.
Resolved
ACH-APIXABAN
5MG · TABLET · ACCORD HEALTHCARE INC
DIN 02487721 · ended Nov 27, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
ACH-APIXABAN
5MG · TABLET · ACCORD HEALTHCARE INC
DIN 02487721 · ended Nov 21, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
ACH-APIXABAN
2.5MG · TABLET · ACCORD HEALTHCARE INC
DIN 02487713 · ended Nov 21, 2025 · Requirements related to complying with good manufacturing practices.
Showing 12 of 32 reports. All reports are on file with Health Canada.
What's happening
A manufacturer has told Health Canada it expects supply of Apixaban to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.
Apixaban is classified under “ANTITHROMBOTIC AGENTS” (ATC B01AF).
Recent changes
Aug 6, 2026
Shortage resolved
Aug 6, 2026
Shortage resolved
Aug 5, 2026
New report filed
Jul 28, 2026
New report filed
Jul 28, 2026
New report filed
Common questions
What is Apixaban used for?
A blood thinner used to prevent and treat blood clots.
When will Apixaban be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Apixaban in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.